LBA87 Phase II LITESPARK-003 study of belzutifan in combination with cabozantinib for advanced clear cell renal cell carcinoma (ccRCC)
Toni K. Choueiri, Todd M. Bauer, Jaime R. Merchan, David F. McDermott, Robert A. Figlin, Edward Arrowsmith, M. Dror Michaelson, Elisabeth I. Heath, Anishka D’souza, Shuang G. Zhao, Loubna Mhamdi, Rodolfo F. Perini, Donna Vickery, Scott S. Tykodi
Topics & Concepts
MedicineCohortInternal medicineCabozantinibOncologySurgeryRenal cell carcinomaRenal cell carcinoma treatmentRenal and related cancersRenal Diseases and Glomerulopathies